Novel benzimidazole-4-carboxylic acid derivatives as potent and selective 5-HT3 receptor ligands

Bioorganic and Medicinal Chemistry Letters

Volumn 6, Issue 11, 1996, Pages 1195-1198

  López Rodríguez, María L ^a   Morcillo, Ma José ^b   Benhamú, Bellinda ^a   Riaguas, Ma Dolores ^a  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^b UNIVERSIDAD NACIONAL DE EDUCACIÓN A DISTANCIA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

BENZIMIDAZOLE DERIVATIVE; CARBOXYLIC ACID DERIVATIVE; SEROTONIN 3 RECEPTOR; SEROTONIN 4 RECEPTOR; SEROTONIN ANTAGONIST; TROPISETRON; ZACOPRIDE;

ANIMAL TISSUE; ANXIETY NEUROSIS; ARTICLE; BINDING AFFINITY; COGNITIVE DEFECT; DRUG POTENCY; DRUG RECEPTOR BINDING; NONHUMAN; RAT; SCHIZOPHRENIA; VOMITING;

ANIMALIA;

EID: 0342748392     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/0960-894X(96)00200-4     Document Type: Article

References (20)

1. (a) Humphrey, P. P. A. 5-Hydroxytryptamine receptors and drug discovery. In Serotonin Receptor Subtypes: Pharmacological Significance and Clinical Implications; Langer, S. Z.; Brunello, N.; Racagni, G.; Mendlewicz, J., Eds.; Karger: Basel, 1992; Vol. 1, pp. 129-139.
2. (b) Peroutka, S. J. The molecular pharmacology of 5-hydroxytryptamine receptor subtypes. In Serotonin Receptor Subtypes: Basic and Clinical Aspects; Peroutka, S. J., Ed.; John Wiley & Sons: New York, 1991.
3. (c) Hemdon, J. L.; Glennon, R. A. Serotonin receptors, agents and actions. In Drug Design for Neuroscience; Kozikowski, A. P., Ed.; Raven Press, Ltd.: New York, 1993; pp. 167-212.
4. (a) Saudou, F.; Hen, R. Med Chem. Res. 1994, 4, 16.
5. (b) Hoyer, D.; Clarke, D. E.; Fozard, J. R.; Hartig, P. R.; Martin, G. R; Mylecharane, E. J.; Saxena, P. R.; Humphrey, P. P. A. Pharmacol. Rev. 1994, 46, 157.
6. (c) Lucas, J. J.; Hen, R. Trends Pharmacol. Sci. 1995, 16, 246.
7. (a) Kilpatrick, G. J.; Bunce, K. T.; Tyers, M. B. Med. Res. Rev. 1990, 10(4), 441.
8. (b) Ford, A. P. D. W.; Clarke, D. E. Med. Res. Rev. 1993, 13(6), 633.
9. (a) Aapro, M. S. Drugs 1991, 42(4), 551.
10. (b) Greenshaw, A. J. Trends Pharmacol. Sci. 1993, 14, 265.
11. King, F. D.; Jones, B. J.; Sanger, G. J. In 5-Hydroxytryptamine-3 Receptor Antagonists; CRC Press: Boca Raton, 1994.
12. (a) Hibert, M. F.; Hoffmann, R.; Miller, R. C.; Carr, A. A. J. Med. Chem. 1990, 33, 1594.
13. (b) Swain, C. J.; Baker, R.; Kneen, C.; Moseley, J.; Saunders, J.; Seward, E. M.; Stevenson, G.; Beer, M.; Stanton, J.; Watling, K. J. Med. Chem. 1991, 34, 140.
14. Williams, A.; Salvadori, G. J. Chem. Soc., Perkin Trans. II 1972, 7, 883.
15. 13 NMR spectra) supported their structural assignment.
16. Nyhammar, T.; Grivas, S. Acta Chem. Scand. 1986, B40, 583.
17. Wong, D. T.; Robertson, D. W.; Reid, L. R. Eur. J. Pharmacol. 1989, 166, 107.
18. Grossman, C. J.; Kilpatrick, G. J.; Bunce, K. T Br. J. Pharmacol. 1993, 109, 618.
19. Robertson, D. W.; Bloomquist, W.; Cohen, M. L.; Reid, L. R.; Schenk, K.; Wong, D. T. J. Med. Chem. 1990, 33, 3176.
20. Clark, R. D.; Weinhardt, K. K.; Berger, J.; Fisher, L. E.; Brown, C. M.; MacKinnon, A. C.; Kilpatrick, A. T., Spedding, M. J. Med. Chem. 1990, 33, 633 .